Evidence map›Paper›PMID 24958900›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Regulation of osteoclast homeostasis and inflammatory bone loss by MFG-E8.

Toshiharu Abe, Jieun Shin, Kavita Hosur, Mark C Udey, Triantafyllos Chavakis, George Hajishengallis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Multi-functional osteoclasts in matrix-based tissue engineering bone.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Toshiharu AbeDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Jieun ShinDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Kavita HosurDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Mark C UdeyCenter for Cancer Research, Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Triantafyllos ChavakisDepartment of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Dresden University of Technology, 01307 Dresden, Germany; and Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Dresden University of Technology, 01307 Dresden, Germany.
George HajishengallisDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; geoh@upenn.edu.
University of Pennsylvania · USNational Institutes of Health · USTU Dresden · DE

Funding

P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
Oral Immunity and Adjuvant ReceptorsR01DE017138 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2006 to 2014
$3.8M
Role of MFG-E8 in Tumor Biology and ImmunophysiologyZIABC010976 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI UDEY, MARK · 2009 to 2017
$2.3M
Novel mechanisms and 'complement-ary' therapy in periodontitisR01DE021685 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2012 to 2016
$2.0M
Intramural NIH HHSNIDCR NIH HHS DE015254NIDCR NIH HHS DE017138NIDCR NIH HHS DE021685NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R01 DE017138NIDCR NIH HHS R01 DE021685
6 · The paper itself

Abstract

The glycoprotein milk fat globule-epidermal growth factor factor 8 (MFG-E8) is expressed in several tissues and mediates diverse homeostatic functions. However, whether it plays a role in bone homeostasis has not been established. In this study, we show for the first time, to our knowledge, that osteoclasts express and are regulated by MFG-E8. Bone marrow-derived osteoclast precursors from MFG-E8-deficient (Mfge8(-/-)) mice underwent increased receptor activator of NF-κB ligand-induced osteoclastogenesis, leading to enhanced resorption pit formation compared with wild-type controls. Consistently, exogenously added MFG-E8 inhibited receptor activator of NF-κB ligand-induced osteoclastogenesis from mouse or human osteoclast precursors. Upon induction of experimental periodontitis, an oral inflammatory disease characterized by loss of bone support of the dentition, Mfge8(-/-) mice exhibited higher numbers of osteoclasts and more bone loss than did wild-type controls. Accordingly, local microinjection of anti-MFG-E8 mAb exacerbated periodontal bone loss in wild-type mice. Conversely, microinjection of MFG-E8 inhibited bone loss in experimental mouse periodontitis. In comparison with wild-type controls, Mfge8(-/-) mice also experienced >60% more naturally occurring chronic periodontal bone loss. In conclusion, MFG-E8 is a novel homeostatic regulator of osteoclasts that could be exploited therapeutically to treat periodontitis and perhaps other immunological disorders associated with inflammatory bone loss.

Indexed as

AnimalsAntigens, SurfaceBone ResorptionCell LineHomeostasisHumansInflammation MediatorsMiceMice, Inbred C57BLMice, KnockoutMilk ProteinsOsteoclastsPeriodontitisRANK LigandStem CellsAntigens, SurfaceInflammation MediatorsMFGE8 protein, humanMilk ProteinsRANK LigandTnfsf11 protein, mouse

Identifiers

PMID24958900
PMCPMC4108495
OpenAlexW2116253816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.